Cushing's syndrome

(redirected from Cushing syndrome)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.

Cushing's syndrome

[′ku̇sh·iŋz ‚sin‚drōm]
(medicine)
A complex of symptoms including facial and truncal obesity, hypertension, edema, and osteoporosis, resulting from oversecretion of adrenocortical hormones.
References in periodicals archive ?
The four endocrine disorders selected for these test strategy paradigms are Cushing syndrome, pheochromocytoma, primary aldosteronism, and hypercalcemia.
A low dose dexamethasone overnight suppression test was carried out in which the patient was administered 1 mg of dexamethasone i/v overnight and the result was serum cortisol 43.5 microgram/dl revealing suppression of the cortisol levels and suggesting that no endogenous abnormality of cortisol secretion by adrenal gland was present ruling out the adrenal cause of cushing syndrome. ACTH levels were performed and the result was elevated serum ACTH levels 205pg/ml (ref: 0-46pg/ml).
Nested stromal epithelial tumor of liver presenting with Cushing syndrome: a rare case report.
Patients with hirsutism due to etiologies other than PCOS like idiopathic hirsutism, Cushing syndrome or late-onset congenital adrenal hyperplasia, pregnant or nursing women and those with any concomitant illnesses or immunosuppression were excluded.
Merke et al., "Altered amygdala and hippocampus function in adolescents with hypercortisolemia: a functional magnetic resonance imaging study of Cushing syndrome," Development and Psychopathology, vol.
(16.) Messina MF, Valenzise M, Aversa S, Arrigo T, De Luca F Iatrogenic Cushing syndrome caused by ocular glucocorticoids in a child.
Nieman, "Cortisolemic indices predict severe infections in cushing syndrome due to ectopic production of adrenocorticotropin," Journal of Clinical Endocrinology and Metabolism, vol.
Table 2 Predictors of non-alcoholic fatty liver disease and metabolic syndrome in non-functioning adrenal adenoma and Cushing Syndrome groups Beta OR P 95%CI Age -0.16 0.984 0.352 0.951-1.018 Model 1 Gender 0.307 1.359 0.519 0.535-3.541 NAFLD Hypercortisolism 1.246 3.476 0.021 1.204-10.036 Age 0.522 1.686 0.069 0.926-1.003 Model 2 Gender 0.269 1.309 0.604 0.473-3.621 NAFLD Hypercortisolism 0.522 1.686 0.373 0.535-5.319 Metabolic 2.215 9.162 <0.001 3.338-25.149 Syndrome Age 0.031 1.032 0.071 0.997-1.068 Model 3 Gender 0.255 1.290 0.603 0.494-3.370 Metabolic Hypercortisolism 2.358 10.571 0.004 2.162-51.688 Syndrome NAFLD, non-alcoholic hepatosteatosis, OR, odds ratio
Ritonavir-fluticasone interaction causing Cushing syndrome in HIV-infected children and adolescents.
While adrenal carcinoma accounts for only approximately 5-10% of cases of Cushing syndrome; approximately 40% of patients with both Cushing syndrome and an adrenal mass have a malignant tumour (2, 3).